Healthy Living Tips

Ozempic Side Effects — Everything You Need to Know

Ozempic Side Effects — Everything You Need to Know

At this, the highest dosage of semaglutide available, an incredible 74 percent of participants experienced at least one gastrointestinal disorder, though it’s worth noting that nearly 50 percent of those who took a placebo also had some tummy troubles.

For some, the gastrointestinal distress is just too much to handle, and they need to stop taking Ozempic entirely. As a blogger for New York magazine’s The Cut put it, “You might go through hell for your post-Ozempic body.” The author spoke to a 42-year-old woman with diabetes who endured “constant nausea” and “power-puking” for weeks, before finally weaning herself off the drug.

In a pivotal trial, 4.5 percent of Wegovy patients stopped taking the medication as a direct result of gastrointestinal disorders — nearly 1 in every 20.

These unfortunate effects are strongest in the days immediately after injecting the once-weekly medication. Patients are also most likely to experience problems when they start on the drug or when they step up to a higher dosage; the side effects commonly fade away as the body gets used to the medicine.

Ozempic Burps

A foul-smelling burp isn’t exactly the most debilitating of side effects, but it can be rather unpleasant. As discussed in many YouTube and TikTok videos, some people taking Ozempic find themselves emitting nasty sulfurous smells when they belch.

There is broad agreement that the burps smell like rotten eggs.

Only a minority of semaglutide trials have identified burping, or “eructation,” as a side effect. Anecdotal reports suggest that the burps, like other gastrointestinal issues, are worse when patients begin taking their drugs or step up to higher dosages.

Bloating and Farting

These uncomfortable side effects were reported in clinical trials as “abdominal distension” and “flatulence.” Bloating and farting complaints are less common than the gastrointestinal effects discussed above, and they have yet to catch on as hot topics on social media, but it’s good to know that Ozempic and related drugs may increase their likelihood.

Stomach Paralysis (Gastroparesis)

Weight loss drugs such as Ozempic have been tied to a rare but increased risk of severe stomach problems. In July 2023, CNN reported that some semaglutide users had experienced gastroparesis, or stomach paralysis, which in some cases did not get better even months after discontinuing the medicine.

Dozens of lawsuits have been filed against the manufacturers of GLP-1 medications alleging that the makers did not sufficiently warn users about the risk of severe side effects such as gastroparesis.

Gastroparesis is a condition in which the stomach empties too slowly or stops; it causes a variety of gastrointestinal symptoms, including bloating, abdominal pain, nausea, and vomiting.

In the worst cases, gastroparesis can make it very difficult to eat or drink anything at all, leading to a risk of dehydration or malnutrition.

Delayed stomach emptying, the defining feature of gastroparesis, is a known consequence of Ozempic and related drugs. This delayed emptying partially accounts for some of Ozempic’s positive effects, helping to reduce hunger and provoke weight loss. It is also responsible for less severe side effects, such as gastrointestinal discomfort.

Luckily, severe and persistent gastroparesis appears to be very rare. The symptom was not identified in any of the drug’s phase 3 trials, which enrolled thousands of participants to evaluate semaglutide’s safety.

Temporary Intestinal Paralysis (Ileus)

Stomach paralysis isn’t the only severe gastrointestinal side effect that users have reported.

In late September 2023, the FDA updated the official Ozempic label to warn users of a potential risk of ileus, a type of intestinal blockage.

 Ileus occurs when the muscles that push food through the intestines are temporarily paralyzed, trapping food within the gut. The symptoms resemble those of a physical bowel obstruction, including bloating and constipation, and the condition can lead to dehydration.

Ileus is likely a rare side effect — it wasn’t identified in previous clinical trials, which evaluated semaglutide in thousands of participants. In its updated guidance, the FDA noted, “Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.”

Leave a Reply

Your email address will not be published. Required fields are marked *